Hippocratic AI, a healthcare AI startup, has secured $141 million in a Series B funding round, bringing its valuation to $1.64 billion. Led by Kleiner Perkins, the round follows a $53 million Series A funding from General Catalyst and Andreessen Horowitz nine months ago, and a $17 million investment from NVIDIA five months later. Despite being less than two years old, Hippocratic AI has rapidly established itself as a leader in generative AI for healthcare, focusing on patient-facing, non-diagnostic tasks to address critical healthcare workforce shortages.
Unlike many healthcare AI companies centered on administrative efficiency, Hippocratic AI develops AI agents to handle tasks such as preoperative preparation, remote patient monitoring, and appointment scheduling, alleviating workloads for doctors and nurses while improving healthcare efficiency. With contracts signed with 23 healthcare systems and insurers as of 2024, the new funding will support product expansion into additional markets and international growth. By leveraging advanced technology, Hippocratic AI aims to transform healthcare delivery, enhance patient experiences, and increase accessibility to services, signaling a shift in how care is provided in an increasingly digitalized healthcare landscape.